50 Cannabis Trivia Questions and Answers (Easy to Expert)
Test your cannabis knowledge with 50 fact-checked questions spanning plant science, history, law, culture, safety, and genuinely odd facts.
Professor High
Think you know cannabis? This 50-question quiz starts with the stuff most curious adults have heard, then wanders into plant biology, brain chemistry, archaeology, federal law, and myths that refuse to retire.
Every answer has been checked against a government source, a peer-reviewed paper, or both. That matters because cannabis trivia is unusually good at turning folklore into “facts.” You will not find invented origin stories, miracle-health claims, or a fake statistic dressed in a lab coat here.
The short version: these are questions you can use at a party, in a classroom, during a 4/20 gathering, or by yourself—with no app and no cannabis required. Click each question to reveal its answer. Laws and policy answers are current as of August 20, 2026, can change, and are not legal advice.
Key Takeaways
- The plant is more chemically and botanically interesting than the familiar leaf symbol suggests.
- THC, CBD, hemp, “indica,” drug tests, and federal legality all carry caveats that make excellent trick questions.
- Cannabis has a long human history, but some of its most famous cultural traditions are surprisingly recent.
- “Natural,” “legal,” and “non-intoxicating” are not synonyms for harmless.
- A perfect score requires knowing when the honest scientific answer is “we do not know yet.”
How to Play
Choose a scorekeeper, read each question aloud, and give players about 15 seconds before revealing the answer. Award one point for the core answer; the explanation is there to settle friendly disputes. For teams, alternate who answers first. Skip any question that feels too personal, and keep the game separate from drinking or consumption challenges.
Scorecard
| Score | Rank | What it means |
|---|---|---|
| 0–10 | Curious Sprout | You came to learn—and you will. |
| 11–20 | Solid Starter | Your foundation is taking root. |
| 21–30 | Budding Scholar | You can separate several facts from folklore. |
| 31–40 | Lab-Coat Legend | You know the science and its limits. |
| 41–49 | Professor’s Rival | Professor High is checking your sources. |
| 50 | Perfect Specimen | Frame the scorecard. Then verify it again. |
Round 1: Easy — Cannabis Basics
1. Which cannabinoid is primarily responsible for the classic cannabis “high”?
Answer: Delta-9-tetrahydrocannabinol, usually shortened to delta-9 THC or THC. The DEA and FDA both identify delta-9 THC as the plant’s main intoxicating or psychoactive component. THC is not the plant’s only cannabinoid, which is why our THC vs. CBD guide uses those initials as a starting point rather than the whole story. (FDA)
2. Does CBD usually produce the same intoxicating high as THC?
Answer: No. CBD is generally considered non-intoxicating, although it still has biological effects and is not risk-free. FDA warns that CBD can cause side effects, affect the liver, and interact with medications—important context for anyone tempted to translate “doesn’t get you high” into “does nothing.” (FDA)
3. Where are cannabinoids most concentrated on a typical cannabis plant?
Answer: In and around the flowering tops, especially their glandular trichomes. Congressional Research Service notes that cannabinoids are generally concentrated in the flowering head rather than the seeds. Leaves can carry trichomes too, but mature flowers are the plant’s resin-rich headquarters. (CRS)
4. What is the process called when heat converts cannabinoid acids such as THCA into neutral cannabinoids such as THC?
Answer: Decarboxylation. Heat and time remove a carboxyl group, releasing carbon dioxide and changing the molecule. The transformation is why raw and heated cannabis are chemically different; our decarboxylation explainer walks through the chemistry without pretending every oven behaves identically. (Livingston et al., 2021)
5. True or false: an edible always takes effect within 15 minutes.
Answer: False. CDC says edible intoxicating effects can take 30 minutes to two hours to appear and may last longer than expected. That delay is why “I don’t feel it yet” is a poor reason to immediately take more. See the beginner edible two-hour rule for a safer pacing framework. (CDC)
6. Can a person develop cannabis use disorder?
Answer: Yes. Cannabis use disorder means someone continues or cannot stop despite meaningful health or social problems. CDC estimates that approximately three in ten people who use cannabis have the disorder, with greater risk among people who start young or use frequently. Our addiction evidence guide explains what that population estimate can—and cannot—predict for one person. (CDC)
7. What is the safest rule about driving after using intoxicating cannabis?
Answer: Do not drive while impaired; arrange another ride. Cannabis can affect coordination, judgment, reaction time, and multitasking. NHTSA also warns that impaired drivers cannot reliably judge their own impairment, so “I feel fine” is not a dependable roadside test. (NHTSA)
8. True or false: because cannabis smoke comes from a plant, it cannot harm lung tissue.
Answer: False. Combustion creates smoke and toxicants regardless of whether the starting material was a plant. CDC says smoking cannabis can harm lung tissue, while the exact long-term risks require more research. Compare routes—not marketing adjectives—in our cannabis and lung health review. (CDC)
9. How many cannabis-derived prescription drug products has the FDA approved?
Answer: One: Epidiolex, a purified CBD product. FDA has also approved three synthetic cannabis-related products—Marinol, Syndros, and Cesamet—but it has not approved the cannabis plant itself to treat a disease or condition. “Sold in a dispensary” and “FDA-approved medicine” are different categories. (FDA)
10. True or false: if adult-use cannabis is legal in a state, every cannabis activity there is legal.
Answer: False. State systems still impose rules on age, possession, cultivation, public use, driving, workplaces, and licensed sales. Federal law also remains separate. Start with our 2026 U.S. legalization overview, then check the current official rules for the exact jurisdiction and activity. (CRS)
Round 2: Medium — Botany and Chemistry
11. Is Cannabis sativa typically grown as an annual or a perennial?
Answer: An annual. In ordinary cultivation it germinates, grows, flowers, sets seed if pollinated, and completes its life cycle in one season. Controlled environments can manipulate the schedule, but that does not turn the species into a botanical perennial. (Andre et al., 2023)
12. What does “dioecious” mean when botanists use it for cannabis?
Answer: Male and female flowers usually occur on separate plants. USDA describes cannabis as normally dioecious while noting that monoecious varieties—with male and female flowers on one plant—also exist. Biology, as usual, makes the clean one-line answer earn an asterisk. (USDA)
13. Are “hemp” and “marijuana” necessarily two different botanical species?
Answer: No. In U.S. policy, the terms primarily describe legal categories based on chemistry and statutory definitions, not two neatly separate species. CRS explains that hemp and marijuana can be cultivars of the same species, Cannabis sativa, while their legal classifications differ. (CRS)
14. What are the tiny resin-producing structures that make cannabis flowers look frosty?
Answer: Glandular trichomes. These epidermal structures include secretory cells and a resin storage cavity. Modern plant-cell research describes mature stalked trichomes as cannabinoid-and-terpene “biofactories,” a more useful mental image than “crystals sprinkled on the flower.” (Hancock, Livingston, and Samuels, 2024)
15. Where do stalked glandular trichomes store much of the resin they produce?
Answer: In an extracellular storage cavity beneath the trichome cuticle. The secretory disc cells build cannabinoids and terpenoids, and the trichome head warehouses the resin above them. It is a microscopic factory with a rooftop tank. (Hancock, Livingston, and Samuels, 2024)
16. In fresh cannabis flower, are THC and CBD usually the dominant forms?
Answer: Not exactly. Fresh flower generally contains more of the acidic precursors THCA and CBDA than neutral THC and CBD. Heat, light, processing, and storage can drive decarboxylation. Read what THCA is before assuming a label’s “total THC” is simply measured delta-9 THC. (Livingston et al., 2021)
17. Which acidic cannabinoid is often nicknamed the “mother cannabinoid” because it feeds several biosynthetic pathways?
Answer: Cannabigerolic acid, or CBGA. Plant enzymes convert CBGA into acidic cannabinoids including THCA, CBDA, and CBCA. The nickname is memorable, but it is shorthand for a branching biosynthetic precursor—not proof that CBG products inherit every claimed benefit of every downstream compound. (Xie et al., 2023)
18. Are terpenes unique to cannabis?
Answer: No. Terpenes are a broad class of compounds made across the plant kingdom. Cannabis produces many of them in its trichomes, but limonene is associated with citrus and pinene with numerous conifers and herbs. Our cannabis aroma science guide separates familiar aroma associations from unsupported effect promises. (Booth and Bohlmann, 2019)
19. Do THC and CBD have the same molecular formula?
Answer: Yes: C₂₁H₃₀O₂. They are structural isomers: the same types and numbers of atoms are connected differently. That small architectural change helps produce dramatically different pharmacology, a terrific reminder that a molecular ingredient list is not a user-experience forecast. (Stella, 2023)
20. Which cannabinoid often increases as THC-rich cannabis ages and oxidizes?
Answer: Cannabinol, or CBN. An analysis of dried cannabis samples from roughly 1896–1905 found much of their cannabinoid content as CBN, described as a main degradation product of delta-9 THC. That does not automatically make old flower a sleep medicine; see our CBN facts-versus-fiction review. (Harvey, 1990)
Round 3: Hard — The Brain, Body, and Research
21. What are the two best-characterized cannabinoid receptors called?
Answer: CB1 and CB2. CB1 is especially abundant in the nervous system, while CB2 has important roles in immune and peripheral tissues, though neither receptor belongs exclusively to one location. Our endocannabinoid system guide maps the system without reducing it to a two-switch cartoon. (National Academies)
22. What body-made cannabinoid-like molecule was first reported in 1992?
Answer: Anandamide, also called arachidonoylethanolamide or AEA. Researchers isolated it from pig brain while searching for a natural molecule that binds cannabinoid receptors. It helped establish that those receptors are part of the body’s own signaling system—not structures waiting around for a plant. (Devane et al., 1992)
23. Where did the name “anandamide” come from?
Answer: From ananda, a Sanskrit word associated with bliss, plus the chemical term “amide.” The playful name came after the molecule’s isolation, not before it. For more on why “your body’s natural THC” is catchy but chemically incomplete, read our anandamide explainer. (NIDA)
24. Which scientist appears on both the 1964 THC-structure paper and the 1992 anandamide paper?
Answer: Raphael Mechoulam. He coauthored the THC paper with Yechiel Gaoni and the anandamide report with William Devane, Lumír Hanuš, and a larger team. The question is about documented authorship, not a one-person “father of everything” legend. (Gaoni and Mechoulam, 1964; Devane et al., 1992)
25. In what year did Yechiel Gaoni and Raphael Mechoulam report the isolation and structure of THC?
Answer: 1964. Their short paper, “Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish,” appeared in the Journal of the American Chemical Society. Naming a famous year is easy; checking the original bibliographic record is the expert move. (American Chemical Society)
26. What active metabolite helps distinguish swallowed THC from inhaled THC?
Answer: 11-hydroxy-THC, usually written 11-OH-THC. The liver’s first-pass metabolism after oral use can produce comparatively important exposure to this active metabolite. That is one reason edible effects can feel different, though dose, food, tolerance, and individual metabolism matter too. See why edibles can hit harder. (Stella, 2023)
27. Which route usually has the faster onset: inhaled cannabis or a conventional edible?
Answer: Inhalation. THC moves rapidly from the lungs into blood, whereas a conventional edible must travel through digestion and first-pass metabolism. Faster does not mean safe, and slower does not mean weak; route changes timing, exposure, and risk. (Huestis et al., 1992; CDC)
28. Is the cannabis “entourage effect” a settled, reliably predictable clinical fact?
Answer: No. Interactions among plant compounds are plausible and some specific combinations deserve study, but a 2024 scoping review found limited evidence for a stable, predictable phenomenon and limited clinical support for broad product claims. Our entourage-effect guide should be read as a framework under investigation, not a guarantee. (Simei et al., 2024)
29. How many milligrams of THC make one “standard THC unit” in NIH-funded human research?
Answer: 5 milligrams. NIH adopted the unit to make exposure reporting more comparable across studies. It is a research measurement, not a universal serving recommendation; the same 5 milligrams can affect people differently based on route, tolerance, biology, and other factors. (NIH)
30. Which three therapeutic uses received conclusive or substantial support in the National Academies’ landmark 2017 review?
Answer: Chronic pain in adults; chemotherapy-induced nausea and vomiting with oral cannabinoids; and patient-reported multiple-sclerosis spasticity symptoms with oral cannabinoids. That carefully bounded list is not proof of effectiveness for every type of pain, nausea, or muscle problem—or for every product. (National Academies)
Round 4: Expert — History, Culture, and Policy
31. About how old is the earliest directly dated chemical evidence of ritual cannabis smoking?
Answer: About 2,500 years old. Researchers detected cannabis biomarkers in wooden braziers from the Jirzankal Cemetery in the eastern Pamirs, dated around 500 BCE. It is strong evidence for burning cannabis during mortuary rites—not proof of every sweeping claim about prehistoric cannabis everywhere. (Ren et al., 2019)
32. What is the most documented origin story for the cannabis term “420”?
Answer: A group of San Rafael High School friends called the Waldos used “420” as a meeting-time code in 1971. Police-code and Bob-Dylan-math explanations are popular myths. Our history of 420 follows the paper trail while acknowledging that cultural origin stories can attract rival claims. (TIME)
33. How did the title of the famous 1937 U.S. federal cannabis tax law spell marijuana?
Answer: “Marihuana,” with an h. The Library of Congress record identifies the Marihuana Tax Act of 1937 and the underlying statute imposed taxes and registration requirements around dealings in “marihuana.” Explore the policy context in our 1937 act history. (Library of Congress)
34. In what year did the United States enact the Controlled Substances Act?
Answer: 1970. Congress created a unified federal scheduling framework and placed marijuana in Schedule I. Our Controlled Substances Act history explains why the law matters far beyond a trivia date. (Congressional Research Service)
35. As of August 20, 2026, what is marijuana’s federal schedule in the United States?
Answer: Schedule I. DEA’s current scheduling page lists marijuana/cannabis among Schedule I substances, and CRS says that status remains despite many state medical and adult-use laws. Scheduling proposals and headlines are not the same as a completed legal change. (DEA; CRS)
36. Which 1996 ballot measure created California’s landmark medical-cannabis protections?
Answer: Proposition 215, the Compassionate Use Act. The official voter guide described protections for qualifying patients and designated caregivers possessing or cultivating cannabis on a physician’s recommendation. It did not make every use or sale legal. (California Secretary of State)
37. Which two U.S. states approved adult-use cannabis ballot measures in November 2012?
Answer: Colorado and Washington. Colorado voters approved Amendment 64, and Washington voters approved Initiative 502. Their rules and implementation timelines were not identical, so “first” is best understood as the pair of states whose voters acted in that election. (Colorado Secretary of State; Washington Legislature)
38. Which country became the first to establish national legal control of adult-use cannabis production and sale?
Answer: Uruguay, in 2013. Law 19.172 put production, distribution, and sale under state control as part of a public-health and harm-reduction policy. “Legal” did not mean an unrestricted commercial free-for-all. (Government of Uruguay)
39. On what date did Canada’s Cannabis Act come into force?
Answer: October 17, 2018. The act created a nationwide framework controlling production, distribution, sale, and possession. Provinces and territories still set many practical rules, and taking cannabis across an international border remains a separate legal issue. (Health Canada)
40. What major federal hemp-definition change is scheduled to take effect on November 12, 2026?
Answer: The U.S. threshold shifts from delta-9 THC alone to total THC, including THCA, and adds product-specific exclusions and limits. As of this article’s August 20 publication date, that change is enacted but not yet effective. Read our 2026 hemp regulation explainer and verify updates before acting. (CRS)
Round 5: Wild Card — Myths, Tests, and Odd Facts
41. Do “indica” and “sativa” labels reliably predict how a product will feel?
Answer: No—not reliably. A study of 89,923 commercial samples across six states found that common retail labels did not consistently align with observed chemical diversity. An individual’s dose, route, tolerance, setting, and biology also shape effects. Our indica-vs.-sativa science review explains why a familiar category can still be a weak prediction tool. (Smith et al., 2022)
42. True or false: most people who use cannabis inevitably progress to “harder” drugs.
Answer: False. CDC says most people who use cannabis do not go on to use other harder drugs. Researchers continue to debate gateway, shared-risk, and social-exposure explanations, so “never related” would also be too absolute. See our gateway-drug evidence review. (CDC)
43. Does holding cannabis smoke in for 20 seconds reliably make the subjective high stronger than a brief hold?
Answer: The controlled evidence says not reliably. In an eight-person study, 0-, 10-, and 20-second breath holds produced typical effects, but there was little evidence that subjective or cognitive response depended on hold duration. Longer holding can increase retention of smoke constituents, so it is not a free upgrade. (Zacny and Chait, 1989)
44. Does passing cannabis smoke through bong water make inhaling it harmless?
Answer: No. Water can cool smoke and change which compounds reach the user, but it does not erase combustion exposure. CDC’s bottom line is simpler: smoked cannabis can harm lung and cardiovascular tissue. A smoother sensation is not a toxicology report. (CDC)
45. Is a fatal overdose caused solely by cannabis likely?
Answer: It appears unlikely—but that does not make overconsumption harmless. CDC documents severe confusion, panic, hallucinations, cardiovascular symptoms, vomiting, injuries, and pediatric poisonings. If someone has trouble breathing, cannot be awakened, has a seizure, or seems in immediate danger, call emergency services; U.S. Poison Control is 1-800-222-1222. (CDC)
46. Can extreme secondhand cannabis smoke exposure ever produce measurable drug-test results?
Answer: Yes, under sufficiently intense conditions—but ordinary casual exposure is not the same experiment. Controlled studies have detected metabolites after dense, poorly ventilated exposure. Ventilation and smoke intensity matter, and a positive metabolite test does not by itself prove impairment. See our THC drug-testing guide. (Law et al., 1984)
47. Can a single blood THC number measure driving impairment the way blood alcohol concentration often can?
Answer: Not reliably. NHTSA reports that blood THC concentration does not correlate neatly with impairment and that no cannabis equivalent of an alcohol BAC test currently quantifies impairment in the same way. The safety rule remains behavioral and simple: do not drive after using an impairing substance. (NHTSA)
48. Are K2 and Spice simply laboratory-made versions of ordinary cannabis?
Answer: No. They are shifting mixtures of synthetic cannabinoid-receptor-active chemicals, often sprayed onto plant material, with unpredictable contents and potentially life-threatening effects. CDC explicitly says that despite the name “synthetic cannabinoids,” these products are not cannabis or cannabinoid medicines. (CDC)
49. Is THC-containing cannabis safe to share with a dog or cat?
Answer: No. ASPCA lists Cannabis sativa as toxic to dogs, cats, and horses, with delta-9 THC as a toxic principle. If a pet may have ingested cannabis—especially an edible that might also contain chocolate or xylitol—contact a veterinarian or animal poison service promptly. (ASPCA)
50. True or false: an unapproved CBD product cannot interact with prescription medication because it is “natural.”
Answer: False. FDA warns that CBD can change how other drugs work and may contribute to serious side effects; it can also cause liver injury. Our 2026 CBD, THC, and prescriptions review is educational, but medication decisions belong with a clinician or pharmacist who knows the full list. (FDA)
The Questions Designed to Trick You
The hardest questions were not the ones with obscure dates. They were the ones where the correct answer needed a boundary:
- CBD is not typically intoxicating, but it can still cause side effects and interactions.
- A state can legalize an activity under state law, but federal law remains separate.
- A test can detect THC or a metabolite, but the number does not translate cleanly into current impairment.
- Plant compounds can interact, but “entourage effect” is not a universal clinical guarantee.
- A fatal outcome solely from cannabis may be unlikely, but poisoning, injuries, and emergencies are real.
That habit—looking for the boundary—is more valuable than memorizing 50 answers. It is also the difference between cannabis education and cannabis marketing.
FAQs
Can I print or copy these cannabis trivia questions for a party?
Yes. A simple format is five rounds of ten, with the host reading the question before expanding the answer. Keep the citations attached if you reproduce the quiz so players can check disputed claims. Do not turn safety questions into consumption dares.
Is this cannabis trivia suitable for a classroom?
The science, botany, history, and policy questions can support adult or college-level discussion. For younger audiences, educators should follow school policy, use neutral language, and emphasize health, legality, and source evaluation. The article is educational, not an invitation to use cannabis.
Why are some answers longer than one word?
Because many popular cannabis “facts” become false when stripped of context. “Hemp equals 0.3% THC,” for example, needs a date, a jurisdiction, a measurement rule, and awareness of a scheduled federal change.
How often should the law questions be updated?
Check them before every republication or event. Federal scheduling, hemp definitions, state programs, and international rules can change. This version was checked on August 20, 2026.
What should I read after finishing the quiz?
Start with the cannabis science guide, then follow your weakest round: endocannabinoid biology, cannabis history, consumption methods, or current U.S. legalization.
Sources
- Ren, M., Tang, Z., Wu, X., Spengler, R., Jiang, H., Yang, Y., & Boivin, N. (2019). The origins of cannabis smoking: Chemical residue evidence from the first millennium BCE in the Pamirs. Science Advances, 5(6), eaaw1391. DOI
- Xie, Z., Mi, Y., Kong, L., Gao, M., Chen, S., Chen, W., Meng, X., Sun, W., Chen, S., & Xu, Z. (2023). Cannabis sativa: origin and history, glandular trichome development, and cannabinoid biosynthesis. Horticulture Research, 10(9), uhad150. DOI
- Hancock, J., Livingston, S. J., & Samuels, L. (2024). Building a biofactory: Constructing glandular trichomes in Cannabis sativa. Current Opinion in Plant Biology, 80, 102549. DOI
- Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949. PubMed
- Stella, N. (2023). THC and CBD: Similarities and differences between siblings. Neuron, 111(3), 302–327. DOI
- Harvey, D. J. (1990). Stability of cannabinoids in dried samples of cannabis dating from around 1896–1905. Journal of Ethnopharmacology, 28(1), 117–128. DOI
- Simei, J. L. Q., Souza, J. D. R., Lisboa, J. R., Campos, A. C., Guimarães, F. S., Zuardi, A., & Crippa, J. A. S. (2024). Does the “Entourage Effect” in Cannabinoids Exist? A Narrative Scoping Review. Cannabis and Cannabinoid Research, 9(5), 1202–1216. DOI
- National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research, published 2017. Conclusions
- U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. FDA
- Centers for Disease Control and Prevention. Cannabis Frequently Asked Questions. CDC
- Congressional Research Service. Changes to the Federal Definition of Hemp: Legal Considerations Under the Controlled Substances Act, updated 2026. Congress.gov
- National Highway Traffic Safety Administration. Drug-Impaired Driving and Marijuana-Impaired Driving. NHTSA
- Booth, J. K., & Bohlmann, J. (2019). Terpenes in Cannabis sativa – From plant genome to humans. Plant Science, 284, 67–72. DOI
- Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498. DOI
- Law, B., Mason, P. A., Moffat, A. C., King, L. J., & Marks, V. (1984). Passive inhalation of cannabis smoke. Journal of Pharmacy and Pharmacology, 36(9), 578–581. DOI
- Zacny, J. P., & Chait, L. D. (1989). Breathhold duration and response to marijuana smoke. Pharmacology Biochemistry and Behavior, 33(2), 481–484. DOI
Professor High’s final ruling: the best trivia answer is the one you can explain, qualify, and source.
